Oxidative stress in schizophrenia: an integrated approach

Area of Science:

• Neuroscience
• Biochemistry

Background:

• Oxidative stress, characterized by damage to lipids, proteins, and DNA, is implicated in schizophrenia's pathophysiology.
• Alterations in enzymatic and nonenzymatic antioxidant systems are observed in schizophrenia patients.
• Experimental models show oxidative stress induces schizophrenia-like behavioral and molecular changes.

Purpose of the Study:

• To explore the link between oxidative stress and schizophrenia pathophysiology.
• To investigate the role of oxidative stress in schizophrenia-related processes.
• To highlight the therapeutic potential of targeting oxidative stress in schizophrenia.

Main Methods:

• Review of current evidence linking oxidative stress to schizophrenia.
• Analysis of experimental models demonstrating oxidative stress-induced anomalies.
• Examination of clinical studies on antioxidant treatments for schizophrenia.

Main Results:

• Oxidative stress is linked to inflammation, oligodendrocyte dysfunction, mitochondrial issues, NMDA receptor hypofunction, and GABA interneuron impairment in schizophrenia.
• These self-sustaining mechanisms may worsen schizophrenia's functional and structural consequences.
• Antioxidant treatments have shown efficacy in improving schizophrenic symptoms.

Conclusions:

• Oxidative stress is a key factor in schizophrenia's development and progression.
• Targeting oxidative stress presents a promising therapeutic strategy for schizophrenia treatment.
• Interventions aimed at reducing oxidative stress could lead to schizophrenia prevention.